Macrogenics Inc
MGNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001125345
In the last 90 days, Macrogenics Inc insiders filed 0 open-market purchases and 1 sale; 122 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Macrogenics Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- −4 vs. Q2 2023
- Shares held
- 58.0M
- −1.98M (−3.3%) vs. Q2 2023
- Total value
- $270.5M
- −$50.6M (−15.8%) vs. Q2 2023
- New holders
- 13
- 45 more added
- Sold out
- 17
- 46 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $224.9M |
| Q1 2026 | 109 | $124.8M |
| Q4 2025 | 89 | $64.3M |
| Q3 2025 | 104 | $77.4M |
| Q2 2025 | 112 | $58.5M |
| Q1 2025 | 129 | $68.3M |
| Q4 2024 | 129 | $182.5M |
| Q3 2024 | 124 | $187.9M |
| Q2 2024 | 147 | $258.9M |
| Q1 2024 | 163 | $953.6M |
| Q4 2023 | 143 | $595.1M |
| Q3 2023 | 127 | $270.5M |
| Q2 2023 | 131 | $321.1M |
| Q1 2023 | 137 | $419.1M |
| Q4 2022 | 135 | $380.5M |
| Q3 2022 | 135 | $199.0M |
| Q2 2022 | 133 | $184.9M |
| Q1 2022 | 144 | $531.2M |
| Q4 2021 | 156 | $918.1M |
| Q3 2021 | 154 | $1.21B |
| Q2 2021 | 149 | $1.54B |
| Q1 2021 | 174 | $1.80B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Macrogenics Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prelude Capital Management, LLC | 10,400 | $48.5K | 0.00% | −2,974−22.2% | Reduced |
| Northeast Financial Consultants Inc | 10,000 | $46.6K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,524 | $39.7K | 0.00% | +3,628+74.1% | Added |
| Legal & General Group Plc | 8,099 | $37.7K | 0.00% | −793−8.9% | Reduced |
| Simplex Trading, LLC | 7,740 | $36.0K | 0.00% | −10,697−58.0% | Reduced |
| Amalgamated Bank | 6,933 | $32.0K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 6,180 | $28.8K | 0.00% | +10+0.2% | Added |
| Ameritas Investment Partners, Inc. | 4,499 | $21.0K | 0.00% | 00.0% | Unchanged |
| Denali Advisors LLC | 4,300 | $20.0K | 0.01% | 00.0% | Unchanged |
| Group One Trading, L.P. | 4,173 | $19.4K | 0.00% | −26,300−86.3% | Reduced |
| Metropolitan Life Insurance Co | 3,285 | $15.3K | 0.00% | 00.0% | Unchanged |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,250 | $10.5K | 0.00% | −744−24.8% | Reduced |
| Citigroup Inc | 2,185 | $10.2K | 0.00% | −18,323−89.3% | Reduced |
| China Universal Asset Management Co., Ltd. | 1,597 | $7.44K | 0.00% | +786+96.9% | Added |
| Spire Wealth Management | 1,114 | $5.19K | 0.00% | +1,114 | New |
| Signaturefd, LLC | 500 | $2.33K | 0.00% | −53−9.6% | Reduced |
| Clear Street Markets LLC | 363 | $2.00K | 0.00% | +363 | New |
| Advisor Group Holdings, Inc. | 402 | $1.87K | 0.00% | +50+14.2% | Added |
| HighMark Wealth Management LLC | 400 | $1.86K | 0.00% | 00.0% | Unchanged |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 213 | $1.09K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 209 | $1.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 117 | $1.00K | 0.00% | +27+30.0% | Added |
| National Bank of Canada | 190 | $849 | 0.00% | 00.0% | Unchanged |
| Farmers & Merchants Investments Inc | 80 | $373 | 0.00% | 00.0% | Unchanged |
| Headlands Technologies LLC | 37 | $172 | 0.00% | +37 | New |
| Sofos Investments, Inc. | 1 | $3 | 0.00% | −4−80.0% | Reduced |
| Capital Advisors, Ltd. LLC | 81 | $0 | 0.00% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −892,579−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −748,679−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −135,150−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −90,723−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −85,829−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −37,988−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −21,976−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −17,542−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −17,132−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −14,787−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −13,838−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −11,950−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −11,088−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −3,315−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −273−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |